“Some of the challenges in SynBio, are the costs and the timelines. Timeline-wise, it takes a while to engineer, as the DBTL (design-build-test-learn) cycles can be anywhere from months to years. And I've seen that firsthand as I was in that industry for years and years.“

-states VP of Business Development at eXoZymes, Zachary Karl, PhD, highlighting some of the challenges of the synthetic biology space - and why he jumped at the opportunity to join eXoZymes, back in September of 2023.